Abstract:Osteogenesis imperfecta (OI) is a heritable and chronically debilitating skeletal dysplasia. Patients with OI typically present with reduced bone mass, tendency for recurrent fractures, short stature and bowing deformities of the long bones. Mutations causative of OI have been identified in over 20 genes involved in collagen folding, posttranslational modification and processing, and in bone mineralization and osteoblast development. In 2016, we described the first X-linked recessive form of OI caused by MBTPS2 missense variants in patients with moderate to severe phenotypes. MBTPS2 encodes site-2 protease, a Golgi transmembrane protein that activates membrane-tethered transcription factors. These transcription factors regulate genes involved in lipid metabolism, bone and cartilage development, and ER stress response. The interpretation of genetic variants in MBTPS2 is complicated by the gene's pleiotropic properties; MBTPS2 variants can also cause the dermatological conditions Ichthyosis Follicularis, Atrichia and Photophobia (IFAP), Keratosis Follicularis Spinulosa Decalvans (KFSD) and Olmsted syndrome (OS) without skeletal abnormalities typical of OI. Using control and patient-derived fibroblasts, we previously identified gene expression signatures that distinguish MBTPS2 -OI from MBTPS2 -IFAP/KFSD and observed stronger suppression of genes involved in fatty acid metabolism in MBTPS2 -OI than in MBTPS2 -IFAP/KFSD; this was coupled with alterations in the relative abundance of fatty acids in MBTPS2 -OI. Furthermore, we observed a reduction in collagen deposition in the extracellular matrix by MBTPS2 -OI fibroblasts. Here, we extrapolate our observations in the molecular signature unique to MBTPS2 -OI to infer the pathogenicity of a novel MBTPS2 c.516A>C (p.Glu172Asp) variant of unknown significance in a male proband. The pregnancy was terminated at gestational week 21 after ultrasound scans showed bowing of femurs and tibiae and shortening of long bones particularly of the lower extremity; these were further confirmed by autopsy. By performing transcriptional analyses, gas chromatography-tandem mass spectrometry-based quantification of fatty acids and immunocytochemistry on fibroblasts derived from the umbilical cord of the proband, we observed perturbations in fatty acid metabolism and collagen production similar to what we previously described in MBTPS2 -OI. These findings support pathogenicity of the MBTPS2 variant p.Glu172Asp as OI-causative and highlights the value of extrapolating molecular signatures identified in multiomics studies to characterize novel genetic variants.

Tendon and motor phenotypes in the Crtap-/- mouse model of recessive osteogenesis imperfecta

Pleiotropic effects of a recessive C mutation occurring in a mouse model of severe osteogenesis imperfecta

Beneficial Effects of Zoledronic Acid on Tendons of the Osteogenesis Imperfecta Mouse (Oim)

Extra-Skeletal Manifestations in Osteogenesis Imperfecta Mouse Models

Tendon-targeted knockout of collagen XI disrupts patellar and Achilles tendon structure and mechanical properties during murine postnatal development

Behavioral signs of pain and functional impairment in a mouse model of osteogenesis imperfecta

Fracture Healing in Collagen‐Related Preclinical Models of Osteogenesis Imperfecta

Effect of Anti‐TGF‐β Treatment in a Mouse Model of Severe Osteogenesis Imperfecta

The IFITM5 mutation in osteogenesis imperfecta type V is associated with an ERK/SOX9-dependent osteoprogenitor differentiation defect

Spatial and temporal expression of molecular markers and cell signals during normal development of the mouse patellar tendon.

Genetic Analysis, Phenotypic Spectrum and Functional Study of Rare Osteogenesis Imperfecta Caused by CRTAP Variants

Dysfunction of Caveolae-Mediated Endocytic TβRI Degradation Results in Hypersensitivity of TGF-β/Smad Signaling in Osteogenesis Imperfecta.

Phenotypic Spectrum in Osteogenesis Imperfecta Due to Mutations in TMEM38B: Unraveling a Complex Cellular Defect

Combinatorial Inhibition of Myostatin and Activin A Improves Femoral Bone Properties in the G610C Mouse Model of Osteogenesis Imperfecta

Temporal Progression of Aortic Valve Pathogenesis in a Mouse Model of Osteogenesis Imperfecta

Perturbations in fatty acid metabolism and collagen production infer pathogenicity of a novel MBTPS2 variant in Osteogenesis imperfecta

Deficient Mechanical Activation of Anabolic Transcripts and Post-Traumatic Cartilage Degeneration in Matrilin-1 Knockout Mice

Novel ActRIIB ligand trap increases muscle mass and improves bone geometry in a mouse model of severe osteogenesis imperfecta

Impaired muscle parameters in adults with mild to severe types of osteogenesis imperfecta: a cross-sectional study

Altered Sox9 and FGF signaling gene expression in Aga2 OI mice negatively affects linear growth

Studies of Chain Substitution Caused Sub-Fibril Level Differences in Stiffness and Ultrastructure of Wildtype and Oim/oim Collagen Fibers Using Multifrequency-Afm and Molecular Modeling.